Browsing by Author "Aslan, F."

Now showing 1 - 3 of 3

Comparison of Hemorrhoid Electrotherapy with Direct Current and Ligasure Hemorrhoidectomy in the Treatment of Hemorrhoidal Disease
(Yuzuncu Yil Universitesi Tip Fakultesi, 2025) Aslan, F.; Oner, M.O.; Binici, S.; Beǧer, B.
Introduction: This study aims to compare LigaSure hemorrhoidectomy and direct current electrotherapy in the treatment of grade 2 and grade 3 internal hemorrhoids. Materıal and Methods: This retrospective study included patients with symptomatic grade 2 or 3 internal hemorrhoids unresponsive to medical treatment. In the galvanization group, hemorrhoidal columns were coagulated using electrotherapy with a current probe set between 2 mA and 16 mA. LigaSure hemorrhoidectomy was routinely performed as an open surgical procedure. Operative time, postoperative pain, length of hospitalization, and clinical stage were recorded. Patients were followed for 3 months to asses s healing, late complications, and recurrence. The patients' follow-ups were conducted via phone up to 2 years. Results: All patients underwent rectoscopy at the 3rd postoperative month. Patients with grade 2 or 3 hemorrhoids, as confirmed by endoscopy and physical examination, were classified as having a recurrence. The LigaSure method showed a sta tistically significant difference in recurrence rates. The mean operative time for the galvanization method was 26 minutes, and this difference was also statistically significant. Pain scores were significantly lower with direct current electrotherapy compared to other methods. Conclusion: Hemorrhoidal coagulation with galvanic electrotherapy reduces operative time and hospitalization duration. Additionally, the relapse rate and postoperative pain, as measured by VAS scores, are lower with this procedure compared to LigaSure hemorrhoidectomy. However, late complications and the intensity of late postoperative pain may be comparable between the two surgical methods. © 2025, Van Medical Journal. All rights reserved.
Fissurectomy and Anocutaneous V-Y Flap in the Treatment of Chronic Anal Fissure: Clinical Experiences in Low Tone Cases
(Yuzuncu Yil Universitesi Tip Fakultesi, 2025) Cikman, O.; Aslan, F.
Chronic anal fissure is a common condition that severely affects the quality of life. For patients who do not respond to medical and conservative treatments, alternative treatment methods such as fissurectomy and anocutaneous V-Y advancement flap application stand out. This study aims to evaluate the outcomes of 53 patients who underwent fissurectomy and anocutaneous V-Y advancement flap treatment as a sphincter-preserving method. This study includes 53 female cases conducted at the Department of General Surgery, Van University Faculty of Medicine, between 2022 and 2024. Parameters such as demographic data (age, gender), number and type of deliveries, clinical features of chronic anal fissures, complications related to wound healing in the postoperative period, recurrence rates, and incontinence were examined. The anocutaneous V-Y advancement flap was successfully applied to all 53 patients, and all patients recovered within an average of 45 days. Only six patients developed wound dehiscence, which was completely healed by the sixth month. At the end of the 12-month follow-up, no recurrence or incontinence was observed in any case. This study demonstrates that the anocutaneous V-Y advancement flap is an effective and safe method for treating chronic anal fissures in patients with low anal tone who have undergone multiple vaginal deliveries. Due to its high success rate, low complication risk, and ability to preserve anal continence, this method should be considered an important alternative in chronic anal fissure treatment. © 2025, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.
Outcomes of Splenectomy for Hematologic Diseases-A Single Center Experience
(Yuzuncu Yil Universitesi Tip Fakultesi, 2021) Çalli, I.; Aslan, F.; İliklerden, Ü.H.; Kiziltan, R.; Kotan, M.Ç.
Splenectomy is a standard, effective and approved approach to the treatment of patients with failed medical treatment who develop recurrent, refractory or chronic diseases. The leading indications for elective splenectomy are benign and malignant hematologic diseases. We present here the findings of a retrospective analysis of the splenectomies performed in a single center for the treatment of hematologic diseases, and the associated outcomes . A retrospective examination was made of 64 patients who underwent splenectomy for the treatment of hematologic diseases at our clinic between 2010 and 2018. The patients were assessed for gender, age, hematologic disease, spleen size, presence of hepatomegaly, presence of accessory spleen, type of surgery (laparoscopic or open), wound site infection, preoperative and postoperative platelet counts, intraoperative and/or postoperative blood replacement, and length of hospital stay. The study sample comprised 23 (36%) male and 41 (64%) female patients, with a mean age of 40.4 years. Of the patients, 51 underwent laparoscopic splenectomy and 13 underwent splenectomy with laparotomy. Of the total, 57 (89%) patients responded fully to the splenectomy, six (9%) patients recorded a partial response and one (2%) patient had no response. Following the splenectomy procedure, one patient developed wound site infection and two patients died due to sepsis. Splenectomy should be considered a good treatment option in hematologic splenic diseases that are resistant to medical treatment, being also associated with low mortality and morbidity. © 2021, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.